Completing data — refresh the page later to see the latest
129176-97-2CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](N)Cc1ccc(Cl)c(Cl)c1)C(=O)N(C(=O)[C@@H]1CCCN1C(=O)[C@H](N)CCCCNC(=O)c1cccnc1)C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1cccnc1AZZJAARMZMEIHY-BBKUSFMUSA-Ntachykinin antagonist
UsesSpantide II, an undecapeptide substance P (SP) analog, is a potent neurokinin-1 receptor (NK-1R) antagonist. Spantide II binds with NK-1R and blocks proinflammatory activities associated with SP. Spantide II can be used in the research of inflammatory skin disorders, such as psoriasis and contact dermatitis[1][2][3].
129176-97-2DTXSID70156088